✦ LIBER ✦

The Pharmacokinetics of Liposomes in Tumor Targeting

✍ Scribed by Hideyoshi Harashima; Hiroshi Kiwada

Book ID: 114176667
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 38 KB
Volume: 40
Category: Article
ISSN: 0169-409X
DOI: 10.1016/s0169-409x(99)00036-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor-Directed Targeting of Liposomes

✍ Yong Serk Park 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 130 KB

Targeting of Liposomes to Tumor Cells in

Targeting of Liposomes to Tumor Cells in Vivo

✍ D. PAPAHADJOPOULOS; A. GABIZON 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 588 KB

Targeting of Liposomes via PSGL1 for Enh

Targeting of Liposomes via PSGL1 for Enhanced Tumor Accumulation

✍ Robert Carlisle, Leonard W. Seymour, Constantin C. Coussios 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 433 KB

Anti-tumor efficacy of tumor vasculature

Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin

✍ Raymond M Schiffelers; Gerben A Koning; Timo L.M ten Hagen; Marcel H.A.M Fens; A 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Truncated bFGF-mediated cationic liposom

Truncated bFGF-mediated cationic liposomal paclitaxel for tumor-targeted drug delivery: Improved pharmacokinetics and biodistribution in tumor-bearing mice

✍ Xianhuo Wang; Linyu Deng; Xiang Chen; Heying Pei; Lulu Cai; Xia Zhao; Yuquan Wei 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Fibroblast growth factor receptors, overexpressed on the surface of a variety of tumor cells and on tumor neovasculature, are potential targets for tumor- and vascular-targeting therapy. The purpose of our present study was to compare the pharmacokinetics and tissue distribution of a novel truncated

Pharmacokinetics and anti-tumor activity

Pharmacokinetics and anti-tumor activity of vincristine encapsulated in sterically stabilized liposomes

✍ Theresa M. Allen; Mary S. Newman; Martin C. Woodle; Eric Mayhew; Paul S. Uster 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 767 KB

Vincristine is used clinically for the treatment of various types of cancer. Recent significant therapeutic improvements obtained by entrapping anthracyclines in sterically stabilized liposomes raised the question whether the therapeutic index of vincristine can be similarly increased by formulation